OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Reduced neutralization of SARS-CoV-2 variants by convalescent plasma and hyperimmune intravenous immunoglobulins for treatment of COVID-19
Juanjie Tang, Youri Lee, Supriya Ravichandran, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 6
Juanjie Tang, Youri Lee, Supriya Ravichandran, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 6
Showing 6 citing articles:
SARS-CoV-2 Antiviral Therapy
Kaiming Tao, Philip L. Tzou, Janin Nouhin, et al.
Clinical Microbiology Reviews (2021) Vol. 34, Iss. 4
Open Access | Times Cited: 57
Kaiming Tao, Philip L. Tzou, Janin Nouhin, et al.
Clinical Microbiology Reviews (2021) Vol. 34, Iss. 4
Open Access | Times Cited: 57
SARS-CoV-2 Variants: A Synopsis of In Vitro Efficacy Data of Convalescent Plasma, Currently Marketed Vaccines, and Monoclonal Antibodies
Daniele Focosi, Marco Tuccori, Andreina Baj, et al.
Viruses (2021) Vol. 13, Iss. 7, pp. 1211-1211
Open Access | Times Cited: 38
Daniele Focosi, Marco Tuccori, Andreina Baj, et al.
Viruses (2021) Vol. 13, Iss. 7, pp. 1211-1211
Open Access | Times Cited: 38
Predicting Vaccine Effectiveness for Hospitalization and Symptomatic Disease for Novel SARS-CoV-2 Variants Using Neutralizing Antibody Titers
Billy J. Gardner, A. Marm Kilpatrick
Viruses (2024) Vol. 16, Iss. 3, pp. 479-479
Open Access | Times Cited: 4
Billy J. Gardner, A. Marm Kilpatrick
Viruses (2024) Vol. 16, Iss. 3, pp. 479-479
Open Access | Times Cited: 4
Are convalescent plasma stocks collected during former COVID‐19 waves still effective against current SARS‐CoV ‐2 variants?
Daniele Focosi, Massimo Franchini, Michael J. Joyner, et al.
Vox Sanguinis (2022) Vol. 117, Iss. 5, pp. 641-646
Closed Access | Times Cited: 12
Daniele Focosi, Massimo Franchini, Michael J. Joyner, et al.
Vox Sanguinis (2022) Vol. 117, Iss. 5, pp. 641-646
Closed Access | Times Cited: 12
Neutralizing Antibodies Against SARS-CoV-2 Variants Induced by Natural Infection or Vaccination: A Systematic Review and Individual Data Meta-Analysis
Xinhua Chen, Zhiyuan Chen, Andrew S. Azman, et al.
SSRN Electronic Journal (2021)
Closed Access | Times Cited: 10
Xinhua Chen, Zhiyuan Chen, Andrew S. Azman, et al.
SSRN Electronic Journal (2021)
Closed Access | Times Cited: 10
Anti-SARS-CoV-2 hyperimmune immunoglobulin provides potent and robust neutralization capacity and antibody-dependent cellular cytotoxicity and phagocytosis induction through N and S proteins
José María Díez, Carolina S. Romero, Maria Cristina Cruz, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 3
José María Díez, Carolina S. Romero, Maria Cristina Cruz, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 3
